Trade PYXS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Pyxis Oncology, Inc. (PYXS) is trading at US$3.33, down 2.35% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$256.9M. Over the past 52 weeks, PYXS has traded between US$1.03 and US$5.55. On Syfe you can trade PYXS with $0 commission and add it to your watchlist.
| Previous close | US$3.41 |
|---|---|
| Market cap | US$256.9M |
| 52-week range | US$1.03 – US$5.55 |
| Volume | 560.12K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Pyxis Oncology, Inc.
Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The firm focuses on the development of product candidates to directly kill tumor cells and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. The company was founded by David Steinberg, Shaan C. Gandhi, and John L. Flavin on June 11, 2018 and is headquartered in Boston, MA.
Year: 2021
Wells Fargo Initiates Pyxis Oncology at Overweight With $12 Price Target
Aug 3, 11:11 AM · MT Newswires
Pyxis Oncology Secures Up to $114 Million Private Placement
Jun 30, 2:30 PM · MT Newswires
Pyxis Oncology, Inc. (PYXS) stock is trading at US$3.33, -2.35% from the previous close of US$3.41.
The market cap for Pyxis Oncology, Inc. (PYXS) stock is approximately US$256.9M.
The 52-week high for Pyxis Oncology, Inc. (PYXS) stock is US$5.55.
The 52-week low for Pyxis Oncology, Inc. (PYXS) stock is US$1.03.
Pyxis Oncology, Inc. (PYXS) does not currently pay a dividend.
Stay on top of PYXS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
